1. Home
  2. CMPS vs HYI Comparison

CMPS vs HYI Comparison

Compare CMPS & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.78

Market Cap

598.7M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset High Yield Defined Opportunity Fund Inc.

HYI

Western Asset High Yield Defined Opportunity Fund Inc.

HOLD

Current Price

$11.01

Market Cap

272.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
HYI
Founded
2020
2010
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
598.7M
272.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CMPS
HYI
Price
$6.78
$11.01
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$16.43
N/A
AVG Volume (30 Days)
1.6M
50.6K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
9.59%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$10.99
52 Week High
$7.13
$12.24

Technical Indicators

Market Signals
Indicator
CMPS
HYI
Relative Strength Index (RSI) 66.43 36.52
Support Level $4.90 $11.04
Resistance Level $5.57 $11.07
Average True Range (ATR) 0.38 0.08
MACD 0.20 0.01
Stochastic Oscillator 84.53 21.74

Price Performance

Historical Comparison
CMPS
HYI

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: